Results 261 to 266 of about 390,053 (266)
Does induction or augmentation of labor increase the risk of postpartum hemorrhage in pregnant women with anemia? A multicenter prospective cohort study in India
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 299-309, April 2025.Abstract Objective
To investigate whether induction/augmentation of labor in pregnant women with anemia increases the risk of postpartum hemorrhage (PPH) and whether this risk varied by indications for labor induction/augmentation and by anemia severity in pregnancy.Tuck Seng Cheng, Farzana Zahir, Carolin Solomi V, Ashok Verma, Sereesha Rao, Saswati Sanyal Choudhury, Gitanjali Deka, Pranabika Mahanta, Swapna Kakoty, Robin Medhi, Shakuntala Chhabra, Anjali Rani, Amrit Bora, Indrani Roy, Bina Minz, Omesh Kumar Bharti, Rupanjali Deka, Charles Opondo, David Churchill, Marian Knight, Jennifer J. Kurinczuk, Manisha Nair +21 morewiley +1 more sourceHigh acceptability of point‐of‐care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 155-162, April 2025.Abstract Objective
Cervical cancer and its precursor are labeled as HIV indicator conditions, justifying the recommendation of HIV testing for all patients. This study aimed to assess the acceptance and patients' and gynecologists' perceptions on HIV testing in patients with cervical dysplasia at the colposcopy outpatient clinic in hospitals in the ...R. L. O. van de Laar, C. C. E. Jordans, A. Salmaan, W. Hofhuis, S. A. H. M. van den Tillaart, I. A. M. van der Avoort, P. J. Timmers, H. J. van Beekhuizen, H. C. van Doorn, C. Rokx +9 morewiley +1 more sourceCost‐effectiveness of a randomized controlled trial comparing low‐dose aspirin to placebo for the prevention of recurrent preterm birth
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 399-407, April 2025.Abstract
To assess the cost‐effectiveness of low‐dose aspirin compared to placebo for the prevention of recurrent preterm birth from a healthcare perspective. This was a cost‐effectiveness analysis alongside a multicenter, randomized, double‐blinded, placebo‐controlled trial.Anadeijda J. E. M. C. Landman, Hana M. Broulikova, Laura Visser, Tobias A. J. Nijman, Marieke A. C. Hemels, Karin C. Vollebregt, Elisabeth M. A. Boormans, Henk A. Bremer, Esther Tuinman, Josje Langenveld, Flip van der Made, Robbert J. P. Rijnders, Huib A. A. M. van Vliet, Liv M. Freeman, Roel de Heus, Judith Blaauw, Ineke Krabbendam, Rafli van de Laar, Marieke F. G. Verberg, Hubertina C. J. Scheepers, Ben W. Mol, Christianne J. M. de Groot, Martijn A. Oudijk, Judith E. Bosmans, Marjon A. de Boer +24 morewiley +1 more sourceGout in pregnancy: Obstetric and neonatal outcomes
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.Abstract Objective
The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan +3 morewiley +1 more source